ID: ALA2442251

Max Phase: Preclinical

Molecular Formula: C128H202N42O43S

Molecular Weight: 3049.34

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

Standard InChI:  InChI=1S/C128H202N42O43S/c1-12-60(6)100(170-115(203)79(35-42-97(183)184)159-107(195)71(21-15-44-142-125(134)135)152-102(190)62(8)150-116(204)85(52-66-56-146-70-20-14-13-19-68(66)70)167-114(202)76(32-38-91(132)174)158-110(198)77(33-40-95(179)180)155-105(193)69(129)29-39-94(177)178)123(211)147-57-93(176)148-61(7)101(189)153-74(30-36-89(130)172)112(200)164-82(49-58(2)3)118(206)157-73(23-17-46-144-127(138)139)108(196)156-72(22-16-45-143-126(136)137)109(197)161-80(43-48-214-11)106(194)149-64(10)104(192)163-87(54-98(185)186)121(209)169-88(55-99(187)188)122(210)165-83(50-59(4)5)119(207)168-86(53-92(133)175)117(205)151-63(9)103(191)154-75(31-37-90(131)173)113(201)166-84(51-65-25-27-67(171)28-26-65)120(208)160-78(34-41-96(181)182)111(199)162-81(124(212)213)24-18-47-145-128(140)141/h13-14,19-20,25-28,56,58-64,69,71-88,100,146,171H,12,15-18,21-24,29-55,57,129H2,1-11H3,(H2,130,172)(H2,131,173)(H2,132,174)(H2,133,175)(H,147,211)(H,148,176)(H,149,194)(H,150,204)(H,151,205)(H,152,190)(H,153,189)(H,154,191)(H,155,193)(H,156,196)(H,157,206)(H,158,198)(H,159,195)(H,160,208)(H,161,197)(H,162,199)(H,163,192)(H,164,200)(H,165,210)(H,166,201)(H,167,202)(H,168,207)(H,169,209)(H,170,203)(H,177,178)(H,179,180)(H,181,182)(H,183,184)(H,185,186)(H,187,188)(H,212,213)(H4,134,135,142)(H4,136,137,143)(H4,138,139,144)(H4,140,141,145)/t60-,61-,62-,63-,64-,69-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,100-/m0/s1

Standard InChI Key:  VKRGYZZRTOSZRW-ZOUZRHFXSA-N

Associated Targets(Human)

SU-DHL10 113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SU-DHL-6 338 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Apoptosis regulator Bcl-2 3787 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3049.34Molecular Weight (Monoisotopic): 3047.4632AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Richard DJ, Lena R, Bannister T, Blake N, Pierceall WE, Carlson NE, Keller CE, Koenig M, He Y, Minond D, Mishra J, Cameron M, Spicer T, Hodder P, Cardone MH..  (2013)  Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker.,  21  (21): [PMID:23993674] [10.1016/j.bmc.2013.08.017]
2. Denis C, Sopková-de Oliveira Santos J, Bureau R, Voisin-Chiret AS..  (2020)  Hot-Spots of Mcl-1 Protein.,  63  (3): [PMID:31580668] [10.1021/acs.jmedchem.9b00983]

Source